From this perspective, our data are inconsistent with other studies analyzing CDH17 immunohistochemical expression, which show an association between low CDH17 and LVI, lymph node metastasis, and advanced stage [23], or between high CDH17 and distant metastases and advanced stage [28,30]. This evidence concerns the gene CDH17 and metastatic malignant neoplasm in the lymph nodes.